Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human SRA1 Anticorps:
anti-Mouse (Murine) SRA1 Anticorps:
anti-Rat (Rattus) SRA1 Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Monoclonal SRA1 Primary Antibody pour IHC, ELISA - ABIN967076
Lanz, Chua, Barron, Söder, DeMayo, OMalley: Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. dans Molecular and cellular biology 2003
Show all 3 Pubmed References
Human Monoclonal SRA1 Primary Antibody pour IHC, ELISA - ABIN969416
Chooniedass-Kothari, Emberley, Hamedani, Troup, Wang, Czosnek, Hube, Mutawe, Watson, Leygue: The steroid receptor RNA activator is the first functional RNA encoding a protein. dans FEBS letters 2004
Show all 3 Pubmed References
Human Monoclonal SRA1 Primary Antibody pour IHC, ELISA - ABIN969417
Chooniedass-Kothari, Hamedani, Troup, Hubé, Leygue: The steroid receptor RNA activator protein is expressed in breast tumor tissues. dans International journal of cancer. Journal international du cancer 2006
Show all 3 Pubmed References
Human Monoclonal SRA1 Primary Antibody pour IP, ELISA - ABIN1742561
Bozdagi, Sakurai, Dorr, Pilorge, Takahashi, Buxbaum: Haploinsufficiency of Cyfip1 produces fragile X-like phenotypes in mice. dans PLoS ONE 2012
Show all 2 Pubmed References
our findings demonstrated that lncRNA SRA is highly correlated with cancer progression and cervical cancer cell proliferation and migration. Furthermore, these results indicate that lncRNA SRA may be a potential therapeutic target and prognostic marker for cervical malignancy.
Surprisingly, Rac1 is not located at the binding site on the Sra1 subunit of the WAVE regulatory complex previously identified by mutagenesis and biochemical data. Rather, it binds to a distinct, conserved site on the opposite end of Sra1.
Steroid receptor RNA activator 1-small interfering RNA treatment significantly increased ER-alpha levels but reduced ER-beta levels in endometriotic stromal cells (ESCs).
These findings suggest that SRA genetic variants may contribute to breast cancer risk
SRA1 was down expressed in HCC and its level was associated with tumor size and GLU level in patients with HCC for the first time. SRA1 may be a helpful biomarker to diagnostic HCC.
By studying a cohort of idiopathic hypogonadotropic hypogonadism, our findings strongly suggest that SRA1 gene function is required for initiation of puberty in humans
Results identified H15-H18 domains in SRA gene playing a key role in regulating ER-mediated transcription.
REVIEW: Biologic function and role in disease
in human pluripotent stem cells SRA interacts with NANOG and is important for maintenance of the pluripotent state.
Data suggest that expression of SRA1 (mRNA and protein) is linked to cancer cell motility (invasiveness of breast/cervical tumor cells) and regulation of gene expression.
lncRNA SRA expression is potentially associated with PCOS and it has positive correlation with obesity in PCOS, thereby suggesting that elevated lncRNA SRA might be an important mediator in adiposity-related processes in PCOS for susceptible individuals.
In endometrioma patients, the surrounding ovarian tissue steroid receptor RNA activator expression is higher compared to controls.
The structure is a five-helix bundle that is distinct from known RNA-binding motifs and instead is similar to the carboxy-terminal domain of the yeast spliceosome protein PRP18, which stabilizes specific protein-protein interactions.
NMR spectra of SRA1p in the presence of its 80-nt RNA target indicate that this protein must be part of a multi-protein complex in order to recognize its proposed RNA recognition element.
This study provides evidence that both ER-beta1 and SRAP could be predictive biomarkers of tamoxifen benefit in ER-alpha-negative premenopausal early breast cancer.
The presence of SRAP and multiple SRAP-like peptides in estrogen receptor positive breast cancer samples correlates with clinical outcome.
results show that the NTD of ERalpha and AR contains a novel RBM that directly binds SRA, and that STR5 can serve as a novel class of RNA inhibitor of ERalpha and AR signaling by interfering with Pus1p-mediated SRA pseudouridylation
A report of the first experimentally derived secondary structure of a human lncRNA, the steroid receptor RNA activator.
A significant (Student's t-test, P < 0.003) higher SRA-intron-1 relative expression is reported in breast tumors with higher progesterone receptor contents.
Alternative splicing of intron-1 is used by breast cancer cells to regulate the balance between coding and functional noncoding SRA1 RNA.
Visfatin upregulated CD36 and SRA expression and downregulated ABCA1 and ABCG1 expression, subsequently increased ox-LDL uptake and decreased cholesterol efflux, and finally promoted foam cell formation via the PI3K- and ERK-dependent pathways.
The results of this study demonstrated that SRA could attenuate microglia mediated inflammation injury in ICH. In addition, SRA mediated negative feedback mechanism in neuroimmune homeostasis.
these data are the first to indicate a functional role for SRA in adipose tissue biology and glucose homeostasis in vivo.
Dax1 augmentation of LRH-1-mediated Oct4 activation is dependent upon steroid receptor RNA activator
DEAD-box RNA helicase p68 (DDX5) and its associated noncoding RNA, steroid receptor RNA activator (SRA), form a complex with CTCF that is essential for insulator function
Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo
Results identify a pseudouridine synthase, mPus1p, as a coactivator for retinoic acid receptor (mRAR)gamma when coexpressed with steroid receptor RNA activator.
both MARCO and SR-A could be involved in the positioning and differentiation of macrophages, possibly through interaction with endogenous ligands
These findings reveal novel functions of SRA and Dax-1 in steroidogenesis and adrenal biology.
Both long non-coding and protein-coding RNAs are transcribed from this gene, and they represent alternatively spliced transcript variants. This gene was initially defined as a non-coding RNA, which is a coactivator for several nuclear receptors (NRs) and is associated with breast cancer. It has now been found that this gene is involved in the regulation of many NR and non-NR activities, including metabolism, adipogenesis and chromatin organization. The long non-coding RNA transcripts interact with a variety of proteins, including the protein encoded by this gene. The encoded protein acts as a transcriptional repressor by binding to the non-coding RNA.
steroid receptor RNA activator 1 (complexes with NCOA1)
, steroid receptor RNA activator protein
, steroid receptor coactivator
, steroid receptor RNA activator 1